Table 3.
Association of walkability category with second visit SBP and second visit DBP.
| Outcomes | Model 1## | P | Model 2## | P |
|---|---|---|---|---|
| Systolic Blood Pressure | β(SE) | β(SE) | ||
| Overall | −0.82(0.65) | 0.21 | −0.38(0.67) | 0.57 |
| Black | −1.16(0.99) | 0.24 | 0.16(1.06) | 0.88 |
| White | −1.39(0.88) | 0.11 | −0.64(0.89) | 0.47 |
| Diastolic Blood Pressure | ||||
| Overall | −0.65(0.41) | 0.12 | −0.52(0.43) | 0.23 |
| Black | –1.52(0.63) | 0.02 | −0.23(0.67) | 0.74 |
| White | −0.54(0.55) | 0.33 | −0.60(0.57) | 0.29 |
Results presented as beta estimates (SD); N = 6,894;
more walkable (Walk Score 70–100) compared to less walkable (<70, reference group); Model 1: Crude; Model 2: age, race, sex, region, income, alcohol use, smoking status, exercise, BMI, dyslipidemia, diabetes, baseline SBP, baseline DBP, and second visit hypertensive medications. Boldface indicates statistical significance (p < 0.05).